Granalix is a startup biotechnology company founded by Prof Ruth Gabizon from the Neurology Department of the Hadassah Medical Center and Prof Shlomo Magdassi, from the Casali Institute of Chemistry of The Hebrew University.

Granagard is the results of their combined experience and knowledge in neurodegenerative diseases and nanotechnology delivery systems. The company was founded under the umbrella of Hadasit and Yissum, the technology transfer companies of Hadassah Medical Center and the Hebrew University of Jerusalem.

The Neurology Department of the Hadassah Medical Center, Jerusalem.

2016-07-18_15-17-32

The Casali Institute of Applied Chemistry, Hebrew University of Jerusalem.

874d85f8-1919-4631-8b10-a12e47bec80b

20160712_153348_1

download   Hebrew_University_new_Logo_2.svg

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Copyright © 2017 Granalix, all rights reserved

Terms of Use

Powered by

‬‏ web-Logo-2

 

Log in with your credentials

Forgot your details?